UVX Inc is a healthcare startup focused on improving disinfection processes using human-safe UV light. The company's flagship product is a ceiling device that utilizes 222nm far-UVC light to eradicate pathogens within seconds, both in the air and on surfaces, without posing risks to humans. Notably, UVX's technology enables continuous sanitation throughout the day, offering a significant improvement over fixed cleaning schedules. The company boasts strong affiliations with UBC’s Faculty of Medicine and has garnered support from prominent healthcare investors like HaloHealth and former AstraZeneca C-Suite. Established in 2021, UVX's innovative solution is being adopted by businesses across North America, earning the trust of health authorities and operators of all sizes. With a focus on the Health Care and Privacy and Security industries, UVX Inc presents a compelling proposition for potential investors seeking exposure to disruptive healthcare technologies.
There is no investment information
No recent news or press coverage available for UVX Inc.